Antigen News and Research

RSS

Kobe University and Sysmex conduct joint research on ELISPOT method for identifying COVID-19

Kobe University and Sysmex Corporation have been engaged in joint research on the ELISPOT method, a new blood test for identifying the novel coronavirus disease (COVID-19).

24 Dec 2020

SARS-CoV-2 mutations may evade T cell immunity

A potentially disturbing new study suggests that SARS-CoV-2 may be undergoing strategic mutations that affect the host immune capacity to recognize and combat the pathogen via T effector cells.

23 Dec 2020

What are the potential benefits of SARS-CoV-2 antigen-based rapid diagnostic tests?

A team of researchers from the Johns Hopkins University, USA; Imperial College London, UK; and Foundation for Innovative New Diagnostics, Switzerland, recently compared the effectiveness of Ag-RDT, NAAT, and clinical judgment alone in the diagnosis of COVID-19 in symptomatic patients.

22 Dec 2020

Self-collected nasal swabs may provide a reliable alternative to nasopharyngeal swabs

Under certain conditions, antigen testing using self-collected swabs from the anterior nose may constitute a reliable alternative to antigen testing using nasopharyngeal swabs collected by health professionals.

22 Dec 2020

Novel microcopy methods used to study tiny traction forces during T-cell activation

Highly complicated processes constantly take place in our body to keep pathogens in check: The T-cells of our immune system are busy searching for antigens - suspicious molecules that fit exactly into certain receptors of the T-cells like a key into a lock.

21 Dec 2020

Researchers demonstrate potential preventive treatment for Crohn's disease

A potential preventive treatment for Crohn's disease, a form of inflammatory bowel disease, has been demonstrated in a mouse model and using immune-reactive T cells from patients with Crohn's disease.

21 Dec 2020

COVID-19 contact tracing ineffective without timely testing and isolation, study says

A new study by Canada-based researchers has showed that contact tracing is not effective if testing and isolation are delayed.

21 Dec 2020

SARS-CoV-2 spike protein remains remarkably conserved among 37 variants from Hong Kong

As the coronavirus disease 2019 (COVID-19) pandemic continues to intensify in many parts of the world, vaccine development is proceeding apace.

21 Dec 2020

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

The onset of the current COVID-19 pandemic revealed the seventh known pathogenic human coronavirus, SARS-CoV-2.

21 Dec 2020

South Korean city shows SARS-CoV-2 clade shift from V to GH over time

A new paper from South Korea describes the evolving SARS-CoV-2 genome in a single city, that of Gwangju, in the southwestern region of this country.

21 Dec 2020

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

There is light at the end of the COVID-19 pandemic tunnel. Several vaccines against the SARS-CoV-2 virus that causes COVID-19 are now in clinical trials, with one -- developed by Pfizer/BioNTech -- already having been approved for emergency use in the United States.

18 Dec 2020

Higher COVID-19 mortality among certain groups in Colombia linked to structural inequalities

Researchers at the Ministry of Health and Social Protection in Bogotá, Colombia, provided evidence of socioeconomic inequalities in COVID-19 deaths in terms of age, sex, ethnicity, type of health insurance regime, and socioeconomic status.

18 Dec 2020

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Abbott announced today it received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test.

18 Dec 2020

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does it completely eliminate tumors in many patients, even when not all the cells in those tumors have the molecular target that the therapy is aimed at?

17 Dec 2020

FDA grants EUA for new COVID-19 viral antigen test

The U.S. Food and Drug Administration granted emergency use authorization (EUA) today for an innovative COVID-19 viral antigen test developed with support from the National Institutes of Health's Rapid Acceleration of Diagnostics (RADx) Initiative.

16 Dec 2020

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

Today, the U.S. Food and Drug Administration issued a new emergency use authorization (EUA) for the BinaxNOW COVID-19 Ag Card Home Test which is authorized for use by patients at home with a prescription.

16 Dec 2020

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Researchers from the University of Rochester, USA, has produced an AI-based study that analyzes the social media platform Twitter to gauge public opinions in the US surrounding SARS-CoV-2 vaccines to shed greater light on this issue.

15 Dec 2020

FDA issues emergency use authorization for first fully at-home OTC COVID-19 diagnostic test

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first over-the-counter (OTC) fully at-home diagnostic test for COVID-19.

15 Dec 2020

Reliable Antibodies Testing for SARS-CoV-2

In this interview, Poncho Meisenheimer, VP of R&D at Promega, talks to News-Medical Life Sciences about the importance of having the reliability for SARS-Co-V-2 antibody tests.

From Promega Corporation 15 Dec 2020

COVID-19 vaccine shows the long-term value of curiosity-driven basic research

The most promising vaccine against the coronavirus to date is also an example of the long-term value of curiosity-driven basic research and its funding by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).

15 Dec 2020

Antigen News and Research

Kobe University and Sysmex conduct joint research on ELISPOT method for identifying COVID-19

SARS-CoV-2 mutations may evade T cell immunity

What are the potential benefits of SARS-CoV-2 antigen-based rapid diagnostic tests?

Self-collected nasal swabs may provide a reliable alternative to nasopharyngeal swabs

Novel microcopy methods used to study tiny traction forces during T-cell activation

Researchers demonstrate potential preventive treatment for Crohn's disease

COVID-19 contact tracing ineffective without timely testing and isolation, study says

SARS-CoV-2 spike protein remains remarkably conserved among 37 variants from Hong Kong

Cross-reactive coronavirus antibodies shape COVID-19 convalescent plasma functionality

South Korean city shows SARS-CoV-2 clade shift from V to GH over time

Research at Advanced Photon Source laid the groundwork for effective COVID-19 vaccines

Higher COVID-19 mortality among certain groups in Colombia linked to structural inequalities

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

FDA grants EUA for new COVID-19 viral antigen test

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

FDA issues emergency use authorization for first fully at-home OTC COVID-19 diagnostic test

Reliable Antibodies Testing for SARS-CoV-2

COVID-19 vaccine shows the long-term value of curiosity-driven basic research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics